-
PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION2023-04-27
-
Next Day Disclosure Return2023-04-21
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 20232023-04-06
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE RESTRICTED SHARE UNIT SCHEME2023-03-31
-
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 20222023-03-27
-
FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 20222023-03-27
-
DATE OF BOARD MEETING2023-03-15
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 20232023-03-02
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 20232023-02-02
-
VOLUNTARY ANNOUNCEMENT - INCLUSION OF FOUR INNOVATIVE DRUGS INCLUDING NEW INDICATIONS IN THE UPDATED NATIONAL REIMBURSEMENT DRUG LIST2023-01-18
-
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL APPROVAL OF ORAL SMALL MOLECULE 3CL PROTEASE INHIBITOR“HS-10517 TABLETS”AGAINST SARS-CoV-22023-01-17
-
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF“HS-10390 TABLETS”2023-01-09
